Alkem Labs block deal: Promoters sell 1.5% in 2026

What happened in Alkem Laboratories

Alkem Laboratories shares were in focus after a large promoter-side sale worth around Rs 930 crore took place on June 2. The transaction was executed through open market block deals and involved about 1.5% of the company’s equity. Exchange data showed the deal price at Rs 5,200 per share. The scale of the sale and the pricing discount to the previous close made it a key market event for the stock.

The sell-down came after reports that the Samprada and Nanhamati Family Trust was looking to offload up to a 1.5% stake in the pharmaceutical company. The eventual transaction size broadly matched that indicated intention. The stake sale was absorbed by a mix of domestic institutions and global investors.

Deal snapshot: size, shares, and price

The block deal involved nearly 17.88 lakh shares, according to exchange data. Another set of block deal data cited 17,88,220 shares representing a 1.49% stake. The average disposal price was Rs 5,200 per share, taking the transaction value to about Rs 929.87 crore, commonly rounded to Rs 930 crore.

The selling price also implied a discount versus the previous closing price. Alkem Laboratories had closed at Rs 5,318 after a decline of 3.3% in Monday’s session. Against that close, the deal price of Rs 5,200 was about 2.2% lower.

Who sold: Jayanti Sinha and the family trust

Two promoter entities were identified as sellers in the transaction. Jayanti Sinha, part of the promoter group, sold her entire 1.04% shareholding. The sale size was 12.38 lakh shares for Rs 643.87 crore. Following this transaction, Jayanti Sinha exited Alkem Laboratories.

The Samprada and Nanhamati Singh Family Trust sold 5.5 lakh shares for Rs 286 crore. The reporting also noted that Sarandhar Singh, on behalf of the Samprada and Nanhamati Singh Family Trust, holds an 18.75% stake in Alkem Labs.

Who bought: nine domestic and global investors

On the buying side, the stake was taken up by nine domestic and global investors. The biggest buyers mentioned were ICICI Prudential Mutual Fund and HDFC Mutual Fund. ICICI Prudential Mutual Fund bought 9.03 lakh shares for Rs 469.83 crore. HDFC Mutual Fund bought 5.09 lakh shares for Rs 265 crore.

Other named buyers included DSP Mutual Fund, BNP Paribas Arbitrage, Societe Generale, Nippon India Mutual Fund, Morgan Stanley Asia Singapore, Goldman Sachs Bank Europe, and Edelweiss Mutual Fund. DSP Mutual Fund bought 86,538 shares for Rs 45 crore. Several other investors were reported to have purchased 48,090 shares each for Rs 25 crore.

Key numbers at a glance

Stock reaction after the block deal

The stock moved lower after the transaction, extending an existing downtrend. Alkem Labs shares fell 1.42% to Rs 5,239 on the National Stock Exchange, according to the report. The prior session also saw weakness, with the stock declining 3.3% to close at Rs 5,318.

Despite the recent two-session decline, the stock was reported to be up about 4.4% over the past one year. In the same period, the Nifty 50 was down around 5.4%, indicating Alkem’s relative outperformance over one year even after the recent dip.

Promoter holding changes after the sale

The transaction also changed the headline promoter holding in the company. After the sale, promoter holding dropped to 49.71% from 51.20%, as per the reported block deal details. This is a notable shift because it moves the promoter group below the 50% mark.

Separately, the reporting highlighted that Jayanti Sinha exited fully after selling her entire stake. The family trust continues to be referenced as a meaningful shareholder through its representation structure.

How the deal was structured and what was disclosed

A term sheet referenced in the coverage indicated a floor price of Rs 5,200 per share and mentioned a 90-day lock-up period on any further sale of shares by the sellers. The term sheet also identified that the trust was represented by authorised individual beneficiaries and sellers Sandeep Singh and Jayanti Sinha.

The trade execution at the floor price aligned with the term sheet indication. The deal’s discount to the prior close suggested the sellers were willing to price for assured demand and swift execution.

Market impact: why investors track promoter block deals

Large block deals tend to draw attention because they increase near-term supply in the stock and can influence trading sentiment. In this case, the stake size was about 1.5% and the deal was priced below the last close, which often becomes a reference point for market participants.

At the same time, the buyer list included multiple large mutual funds and global institutions, signalling that there was enough institutional appetite to absorb the sale at the agreed level. The immediate market reaction still reflected caution, with the stock closing lower on the day of reporting.

Conclusion: what to watch next

The June 2 block deal in Alkem Laboratories was a promoter-led divestment of about 1.5% equity at Rs 5,200 per share, totalling around Rs 930 crore. The transaction led to Jayanti Sinha’s full exit and reduced total promoter holding to 49.71% from 51.20%.

Going forward, the key reference points for investors remain the deal price (Rs 5,200), subsequent stock performance after the two-session decline, and any disclosures linked to the stated 90-day lock-up period mentioned in the term sheet.